Literature DB >> 17917028

Chimerism and tetragametic chimerism in humans: implications in autoimmunity, allorecognition and tolerance.

Edmond J Yunis1, Joaquin Zuniga, Viviana Romero, Emilio J Yunis.   

Abstract

The presence of cells or tissues from two individuals, chimeras, or the presence of cells and tissues that include the gonads, tetragametic chimerism can be detected by the analysis of cytogenetics and analysis of polymorphic genetic markers, using patterns of pedigree inheritance. These methodologies include determination of sex chromosomes, major histocompatibility complex (MHC) polymorphisms and panels of short tandem repeats (STRs) that include mitochondrial DNA markers. Studies routinely involve cases of temporal chimerism in blood transfusion, or following allotransplantation to measure the outcome of the organ, lymphopoietic tissues or bone marrow grafts. Demonstration of persistent chimerism is usually discovered in cases of inter-sexuality due to fusion of fraternal twins or in cases of fusion of embryos with demonstrable allogeneic monoclonality of blood which, excluded maternity or paternity when blood alone is used as the source of DNA. In single pregnancies it is possible to produce two kinds of microchimerism: feto-maternal and materno-fetal, but in cases of fraternal twin pregnancies it is possible to identify three different kinds which are related to cases of vanishing twins that can be identified during pregnancy by imaging procedures; (1) hematopoietic, (2) gonadal, and (3) freemartins when the twins have different sex and the individual born is a female with either gonadal or both gonadal and hematopoietic tissues. Fraternal twin pregnancies can also produce fusion of embryos. Such cases could be of different sex presenting with inter-sexuality or in same sex twins. One of such cases, the best studied, showed evidence of chimerism and tetragametism. In this regard, the case was studied because of disputed maternity of two of her three children. All tissues studied, except for the blood, demonstrated four genetic components but only two in her blood of four possible showed allogeneic monoclonality consistent with the interpretation that her blood originated from one hematopoietic stem cell. Also, microchimerism, due to traffic of cells via materno-fetal or feto-maternal has been prompted by reports of their potential association with the development of autoimmune disorders including systemic lupus erythematosus (SLE) and systemic sclerosis, and in allotransplantation. In addition, their relevance of chimerism in the positive and negative selection of T cells in the thymus has not been addressed. T lymphocytes play a central role in controlling the acquired immune response and furthermore serve as crucial effector cells through antigen specific cytotoxic activity and the production of soluble mediators. Central tolerance is established by the repertoire selection of immature T lymphocytes in the thymus, avoiding the generation of autoreactive T cells. Expression of chimeric antigens in the thymus could modify the generation of specific T cell clones in chimeric subjects and these mechanisms could be important in the induction of central tolerance against foreign antigens important in allo-transplantation. In this review, we discuss the genetics of chimerism and tetragametism and its potential role in thymic selection and the relevance in allotransplantation and autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917028     DOI: 10.1007/s12026-007-0013-3

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  127 in total

Review 1.  Thymic selection revisited: how essential is it?

Authors:  Harald von Boehmer; Iannis Aifantis; Fotini Gounari; Orly Azogui; Loralee Haughn; Irina Apostolou; Elmar Jaeckel; Fabio Grassi; Ludger Klein
Journal:  Immunol Rev       Date:  2003-02       Impact factor: 12.988

Review 2.  Understanding crypticity is the key to revealing the pathogenesis of autoimmunity.

Authors:  Kamal D Moudgil; Eli E Sercarz
Journal:  Trends Immunol       Date:  2005-07       Impact factor: 16.687

3.  Quantification of chimerism within peripheral blood, bone marrow and purified leukocyte subsets: comparison of singleplex and multiplex PCR amplification of short tandem repeat (STR) loci.

Authors:  O Beck; C Seidl; T Lehrnbecher; H Kreyenberg; D Schwabe; T Klingebiel; E Seifried; P Bader; U Koehl
Journal:  Eur J Haematol       Date:  2006-03       Impact factor: 2.997

Review 4.  The influence of inherited and noninherited parental antigens on outcome after transplantation.

Authors:  Daniëlle E M van den Boogaardt; Jon J van Rood; Dave L Roelen; Frans H J Claas
Journal:  Transpl Int       Date:  2006-05       Impact factor: 3.782

5.  Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis.

Authors:  C M Artlett; J B Smith; S A Jimenez
Journal:  N Engl J Med       Date:  1998-04-23       Impact factor: 91.245

6.  Fertility of sperm from a tetraparental chimeric bull.

Authors:  C Sumantri; A Boediono; M Ooe; S Saha; T Suzuki
Journal:  Anim Reprod Sci       Date:  1997-03       Impact factor: 2.145

7.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.

Authors:  H Pircher; K Bürki; R Lang; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

8.  Microchimerism of maternal origin persists into adult life.

Authors:  S Maloney; A Smith; D E Furst; D Myerson; K Rupert; P C Evans; J L Nelson
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

9.  Importance of chimerism in maintaining tolerance of skin allografts in mice.

Authors:  D M Lubaroff; W K Silvers
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

10.  Complete MHC haplotype sequencing for common disease gene mapping.

Authors:  C Andrew Stewart; Roger Horton; Richard J N Allcock; Jennifer L Ashurst; Alexey M Atrazhev; Penny Coggill; Ian Dunham; Simon Forbes; Karen Halls; Joanna M M Howson; Sean J Humphray; Sarah Hunt; Andrew J Mungall; Kazutoyo Osoegawa; Sophie Palmer; Anne N Roberts; Jane Rogers; Sarah Sims; Yu Wang; Laurens G Wilming; John F Elliott; Pieter J de Jong; Stephen Sawcer; John A Todd; John Trowsdale; Stephan Beck
Journal:  Genome Res       Date:  2004-05-12       Impact factor: 9.043

View more
  6 in total

1.  Blood and marrow transplantation: a perspective from the University of Minnesota.

Authors:  John H Kersey
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

2.  Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?

Authors:  Rachel Mitchell; Lela Buckingham; Melody Cobleigh; Jacob Rotmensch; Kelly Burgess; Lydia Usha
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

3.  Analysis of maternal microchimerism in rhesus monkeys (Macaca mulatta) using real-time quantitative PCR amplification of MHC polymorphisms.

Authors:  Sonia Bakkour; Chris A R Baker; Alice F Tarantal; Li Wen; Michael P Busch; Tzong-Hae Lee; Joseph M McCune
Journal:  Chimerism       Date:  2014-01-17

Review 4.  The role of mitochondria in rheumatic diseases.

Authors:  Yann L C Becker; Bhargavi Duvvuri; Paul R Fortin; Christian Lood; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2022-09-29       Impact factor: 32.286

5.  Zygotes segregate entire parental genomes in distinct blastomere lineages causing cleavage-stage chimerism and mixoploidy.

Authors:  Aspasia Destouni; Masoud Zamani Esteki; Maaike Catteeuw; Olga Tšuiko; Eftychia Dimitriadou; Katrien Smits; Ants Kurg; Andres Salumets; Ann Van Soom; Thierry Voet; Joris R Vermeesch
Journal:  Genome Res       Date:  2016-04-12       Impact factor: 9.043

6.  Somatic variants of potential clinical significance in the tumors of BRCA phenocopies.

Authors:  Lela Buckingham; Rachel Mitchell; Mark Maienschein-Cline; Stefan Green; Vincent Hong Hu; Melody Cobleigh; Jacob Rotmensch; Kelly Burgess; Lydia Usha
Journal:  Hered Cancer Clin Pract       Date:  2019-07-16       Impact factor: 2.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.